EyePoint Pharmaceuticals
EYPT
EYPT
45 hedge funds and large institutions have $22.9M invested in EyePoint Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
15% more funds holding
Funds holding: 39 → 45 (+6)
Holders
45
Holding in Top 10
–
Calls
$347K
Puts
$174K
Top Buyers
| 1 | +$3.17M | |
| 2 | +$433K | |
| 3 | +$334K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$280K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$201K |
Top Sellers
| 1 | -$151K | |
| 2 | -$71K | |
| 3 | -$68K | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$63K |
| 5 |
Walleye Trading
New York
|
-$26.5K |